GW & Wade’s Aceragen Inc ACGN Stock Holding History

GW & Wade’s Portfolio ACGN Stock Details ACGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,059	Closed	-$12K	–	392
2022 Q4	$12K	Sell	2,059 -2	-0.1%	-$12	﹤0.01%	382
2022 Q3	$13K	Hold	2,061	–	–	﹤0.01%	378
2022 Q2	$16K	Hold	2,061	–	–	﹤0.01%	381
2022 Q1	$18K	Hold	2,061	–	–	﹤0.01%	389
2021 Q4	$20K	Hold	2,061	–	–	﹤0.01%	389
2021 Q3	$36K	Hold	2,061	–	–	﹤0.01%	378
2021 Q2	$42K	Hold	2,061	–	–	﹤0.01%	382
2021 Q1	$46K	Buy	+2,061	New	+$154K	﹤0.01%	353

Other funds holding ACGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Agricole Montrouge Cedex, France $38.1B AUM

HCM

Hollencrest Capital Management Newport Beach, California $2.7B AUM 23.62% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

GW & Wade's ACGN Position: Q1 2023 in Review

GW & Wade sold out of Aceragen Inc (ACGN) in Q1 2023, closing a stake of 2,059 shares — an estimated $12K sold.

GW & Wade first reported a position in ACGN in Q1 2021 and held it in 8 quarters. The position peaked at $46K in Q1 2021. 19 funds tracked by Wall St. Rank hold ACGN as of Q1 2023.

GW & Wade reported no remaining Aceragen Inc position as of Q1 2023 after selling out during the quarter.
GW & Wade sold 2,059 Aceragen Inc shares in Q1 2023, an estimated $12K.
GW & Wade first reported a position in Aceragen Inc in Q1 2021 and held it in 8 quarters.
GW & Wade's Aceragen Inc position peaked at $46K in Q1 2021.
19 funds tracked by Wall St. Rank held Aceragen Inc as of Q1 2023.

Based on GW & Wade's 13F filing for Q1 2023, filed 9 May 2023.